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In attempting to induce the adaptation of a  strain of human in- 
fluenza virus, PR8  (1),  to the central nervous system of mice, large 
doses of virus suspension were given intraperitoneally to the animals 
while simultaneous injections of meat infusion broth were made intra- 
cerebrally.  No external evidence of infection was noted, but when the 
mice  were  sacrificed  on  the  7th  day  after  inoculation  pulmonary 
lesions of moderate extent were observed.  The lesions in the gross 
were quite characteristic of those produced in the lungs of mice by the 
intranasal  inoculation of  influenza virus.  They  consisted of  plum 
colored areas of edematous pneumonia involving one-fourth to one- 
half the lung tissue.  Since no evidence had previously been obtained 
to  suggest that  pulmonary infection occurred with  influenza virus 
administered by other than the intranasal route, further studies were 
undertaken to determine the distribution of virus in the animal body 
after inoculation by various routes. 
While the present work was in progress, Smorodintsev and his co- 
workers (2) reported certain results showing that influenza virus could 
be recovered from the blood of mice for a period after its introduction 
into the peritoneal cavity but observed no pulmonary lesions.  The 
present report is primarily concerned with the localization and survival 
of influenza virus in various organs of mice, especially the lungs, after 
its inoculation by the intraperitoneal route. 
Materials  and Methods 
The PR8 strain of epidemic influenza virus maintained in mice through 150 to 
240  serial  intranasal  passages  was  used  throughout.  Intranasal  inoculation  of 
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normal mice with 0.05 cc. of a 1 : 1 million dilution of infected mouse lung suspen- 
sion almost invariably caused a fatal disease with typical, extensive  pulmonary 
lesions, while with a  1 : 10 million dilution  lesions were invariably produced  with 
but occasional fatalities.  The lethal end point of the virus  is,  therefore,  con- 
sidered to be 1 : 1 million, and 0.05 cc. of the 10 per cent suspension represents  on 
the average  100,000 intranasal minimal lethal doses (M.LD.). 
Tests for virus were made by emulsifying the lungs of mice in meat infusion 
broth and subsequently  inoculating  this material into the nostrils of normal mice 
lightly anesthetized  with ether  (1, 3).  Mice which  received  intraperitoneal  or 
subcutaneous  inoculations  of virus were lightly  anesthetized  with ether and the 
material was administered  from syringes through needles of 25 or 27 gauge.  To 
avoid leakage and the consequent  danger of accidental  nasal  contamination the 
site of inoculation was immediately painted with flexible collodion.  The efficacy 
of this procedure in eliminating  intranasal infection was shown by experiment  in 
which virus was applied  to the skin and the area painted with collodion.  The 
lungs of mice so treated were tested for virus from 2 to 8 days after the application 
of virus to the skin.  In no instance,  even after serial passage, was virus demon- 
strable  in the lungs.  Other mice  treated in a  similar  manner were  tested for 
immunity by intmnasal  test  14  days later  and  were  found  to  be  completely 
susceptible. 
Neutralization tests for the identification  of virus were carried out with normal 
serum  and with known immune serum  according  to the technique  described  by 
Francis  and Magill  (4). 
The term, minimal  lethal doses (M.L.D.), refers throughout to fatal doses as 
measured by intranasal infection of mice. 
The Specificity of Pulmonary Lesions in Mice Following  Intraperitoneal 
Inoculation of Virus 
In a preliminary effort to determine whether the pulmonary lesions 
observed in mice after intraperitoneal injection of influenza virus were 
associated  with  the  presence  of  influenza  virus  in  the  lungs,  the 
following experiment was conducted. 
To each of 4 anesthetized  mice was given intraperitoneally  0.5 cc. of a  10 per 
cent suspension of the lungs of mice infected with the 149th mouse passage of the 
PR8 strain of epidemic influenza  virus.  On the 5th day after inoculation  the 
mice  were  sacrificed  and  the  lungs  examined.  Pulmonary  lesions  of  + + +, 
+ +, + +, +  severity, respectively, were noted.  Passage made with suspensions 
of these lungs to normal mice resulted in fatal infections with complete pulmonary 
involvement.  Neutralization  tests  with  known  immune  serum  demonstrated 
the presence of epidemic influenza virus in the involved lungs. 
Attempts to induce similar  changes in the lungs of etherized mice 
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were unsuccessful.  On the other hand, lesions were produced in the 
lungs of mice after intraperitoneal injection of virus even in the absence 
of ether anesthesia, demonstrating that etherization played no essen- 
tial r61e in the development of the lesions.  Using similar procedures 
it was established by repeated experiments that the lesions are asso- 
ciated with the presence of influenza virus in the lungs of the mice 
although virus may be present in  the absence of gross pulmonary 
damage. 
TABLE  I 
Variation  in  Pulmonary  Lesions Produced by  Different, Large Intraperitoneal 
Doses of Virus 
I 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
5 
2 
1 
2 
10 
10 
5 
5 
2 
2 
2 
2 
1 
1 
0.5 
0.5 
0.5  500,00C 
0.5  200,00(3 
0.5  100,00(3 
0.5  200,00~ 
0.5  1,000,OOC 
0.1  IO0,OOC 
0.5  500,00C 
0.2  200,OOE 
2.0  800,OOG 
1.0  400,O(E 
0.5  200,00(] 
0.1  40,00~ 
1.0  200,00~ 
0.5  IO0,OOG 
2.0  200,00~ 
0.5  50,000 
6th 
6th 
6th 
6th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
4th 
Pulmonary lesions noted 
+  0  0  0  0 
+++  ++  +  0  0 
4-  0  0  0  0 
++  ++  ++  +  -~-  0  0  0¢ 
0  0  0  0  0  0 
0  0  0  0  0  0  0 
++  ++  +  +  +  +  + 
++  ++  ++  ++  +  +  +  0 
++  ++  ++  +  0 
++  ++  ++  ++  ++  +++  + 
+  +  4-  4-  0  0  0  0 
+  0  0  0  0  0  0  0 
+  +  +  +  0  0  0  0 
++  +  +  0  0  0  0  0 
+  +  0  0  0  0  0  0 
-I-  +  0  0  0  0  0  0 
The Frequency of Occurrence of Virus and Lesions in the Lungs of Mice 
after Intraperitoneal Inoculation of Virus 
In Table I  is presented the incidence of pulmonary lesions in  16 
groups  of  mice  receiving  relatively  large  doses  of  virus  intraperi- 
toneally.  Considerable variation was observed in the frequency with 
which pulmonary lesions occurred in different groups of mice receiving 
the same dose of virus.  Within the range of dosage employed in this 
series (50,000 to 1 million intranasal M.L.D.), no consistent relationship 
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monary  involvement  was  detectable.  Furthermore,  the  variation 
exhibited  by animals of the  same group  suggests  that within  these 
limits  the  individual  reaction  is  perhaps  of  greater  importance  in 
determining pulmonary involvement than the dose of virus employed. 
This fact is clearly illustrated by the following experiment. 
TABLE  II 
Titrations of Amount of Virus Present in the Lungs of Individual Mice 4 Days after 
Intraperitoneal Inoculation 
Lung lesions 
Mouse No.  after intra- 
peritoneal 
inoculation 
I  0 
2  0 
3  0 
4  0 
Results of intranasal inoculation of mice with dii~erent dilutions of test 
suspensions 
10-1 
0 
o 
o 
o 
5 
7 
5 
7 
4 
4 
10-: 
o 
o 
o 
o 
7 
7 
6 
7 
4 
6 
101 
o 
o 
o 
o 
7 
8 
8 
9 
6 
7 
10-4  10-5  10-8 
o  o 
0  o 
o  o 
o  o 
++  + 
++  o 
;  * 
o 
7+  +++ 
+  +  + 
In Tables II, III, IV, VII. 
Numerals indicate day of death of test mice 
+  to  +-}--[--}-  =  progressive  degrees of 
surviving mice autopsied on 10th day. 
0 = no gross pulmonary lesions. 
with typical + + + +  lesions. 
gross pulmonary involvement in 
Five mice were given 0.5 cc. of 1 per cent mouse lung virus suspension (100,000 
intranasal M.L.D.) intraperitoneaUy.  The mice were sacrificed and autopsied on 
the 4th day after inoculation.  The lung lesions were noted and titrations of the 
virus content of the individual lungs were made. 
The results are shown in Table II.  It is seen that neither virus nor 
lesions were present in the lungs of 2  of the  mice,  while virus was 
present in large amounts (1,000 to 100,000 ~.L.D.) in the lungs of the 
other  3  mice  although in  only  1  was  evidence of gross  pulmonary 
involvement observed. E~  R.  RICKARD  AND  THOMAS  FRANCIS,  JR.  957 
Owing to variation  in individual mice the minimal  intraperitoneal 
dose of virus which results in the appearance of lesions or virus in the 
lungs has not been subject to determination with the same accuracy 
as in  the  case of virus  administered  intranasally.  There  has  been, 
nevertheless, a  relatively sharp boundary between effective and non- 
effective doses.  The  injection  of  100,000 ~.L.D.  intraperitoneally  is 
invariably followed by the appearance of virus in the lungs of a large 
proportion  of  the  inoculated  mice.  With  10,000  ~r.L.D. virus  was 
recovered  in  only  one  of  several  attempts.  When  intraperitoneal 
doses of  1,000 ~.L.D.  were given, virus was not demonstrable in the 
lungs over a  period of 1 to 4 days, even with the  secondary passage 
technique  employed  by  the  Russian  investigators  (2).  Paralleliu~r 
to a certain extent the presence of virus in the lungs, lesions have been 
observed in  the  lungs,  but for one  exceptional  instance,  only when 
doses greater than 10,000 ~r.L.D. have been given intraperitoneally. 
It is readily apparent,  therefore,  that the intraperitoneal  injection 
of influenza virus is followed by the appearance of virus and the asso- 
ciated lesions in the lungs of mice only after large amounts of virus are 
used.  When  less  than  10,000  intranasal  ~r.L.D. were  given  intra- 
peritoneally,  no  evidence of the  presence  of virus in  the  lungs  was 
obtained. 
Search for Virus and Lesions in the Lungs of Mice at Daily Intervals 
after Intraperitoneal Inoculation 
The foregoing results were based on observations made to a  great 
extent on the 4th day after intraperitoneal  inoculation of virus.  To 
determine the length of time through which virus and lesions could be 
detected in the lungs after the introduction of virus into the peritoneal 
cavity, the following experiments were conducted. 
Each of 15 mice in series A was given 0.5 cc. of 2 per cent virus suspension 
(200,000 ~t.L.~.) intraperitoneally  with the aid of ether anesthesia.  To 29 mice 
of series B, 0.5 cc. amounts of 10 per cent virus suspension (1 million ~r.L.D.) were 
given intraperitoneally  without the use of ether.  Groups of 3 to 5 mice were 
killed at daily intervals, the presence of pulmonary lesions noted, and the pooled 
lungs of each group made into 20 per cent suspensions which were then tested for 
the presence of virus by intranasal  inoculation into 3 normal mice.  These test 
mice were observed for 10 days and the day of death and the lung lesions were 
recorded.  All survivors were sacrificed and examined on  the  10th  day.  The 
results are tabulated in Table III. 958  LESIONS  IN  INFLUENZA  VIRUS-INOCULATED LUNGS 
In both series of mice virus was recovered from the lungs as early as 
24 hours after its intraperitoneal administration and, as judged by the 
time of death of the test mice, reached its height on the 4th day, at 
which  time pulmonary lesions  were  first  observed.  In  series  B  a 
gradual decrease in the amount of virus occurred after the 4th day so 
that by the 7th day virus was not detectable, and the lesions observed 
TABLE  HI 
Search for Virus and Pulmonary Lesions in the Lungs of Mice at Daily Intervals after 
Intraperitoneal Inoculation of Virus 
Day m ¢¢ 
tilled al .tier 
intrape ~'-  Number  ] 
oneal i~ koc-  of mice 
ulatio 1  in group 
1st  3 
2nd  3 
3rd  3 
4th  3 
5th  3 
6th 
7th 
Series A 
Lesions noted 
0  0  0 
0  0  0 
0  0  0 
+  +  o 
++  ++  0 
Day of 
death of 
test mice 
with  ++++ 
legions 
6, 7, 8 
4,4,5 
3, 6, 6 
3, 3, 4 
4,4,5 
Number 
~f  mice 
m group 
S~i~ B 
LeMons noted 
0  0  0 
0  0  0 
0  0  0  0 
+  +  +  + 
++  0  0  0 
+  +  0  0 
++  +  +  0* 
Day of 
death of 
test mice 
with  ++++ 
lesions 
8, 8, 8 
6, 6, 7 
6, 6, 7 
0  5, 5, 6 
0  7, 8, 8 
0  8, 9, 10 
0, 0, 0 
* Lesions of a greyish appearance commonly seen in mice surviving sublethal 
intranasal doses. 
in the lungs at that time were of a pale greyish appearance character- 
istic of the healing process.  It was also of interest that the use of 
ether exerted no apparent influence upon the outcome of the experi- 
ment. 
Subsequent studies were then conducted to ascertain by titration 
the relative amounts of virus present in the lungs of mice at daily 
intervals after intraperitoneal injection. 
Intraperitoneal  injections of 0.5  cc.  amounts  of  I  per  cent virus  suspension 
were made in 21 mice.  The aninmls were sacrificed in groups of 3 at daily intervals 
from I  to 7 days after inoculation.  No pulmonary lesions were observed.  The 
lungs of each group were pooled and broth suspensions in dilutions of from 10  -1 to 
10  -e  were inoculated  intranasally  into  test  mice.  The  mice were observed  for 
10 days at the end of which time the survivors were sacrificed and the presence or E. R. RICKARD  AND  THOMAS  ]~RANCIS,  JR.  959 
absence of pulmonary lesions noted.  The results of the titrations are presented in 
Table IV. 
It is seen that while virus was present in the lungs 24 hours after its 
intraperitoneal administration the amount was comparatively small. 
TABLE  IV 
Titration of Amounts of Virus Present at Daily Intervals in the Lungs of Mice after 
Intraperitoneal Inoculation 
Da~ after intra- 
peritoneal inocu- 
lation 
Ist 
2nd 
3rd 
4th 
5th 
6th 
7th 
Day of death of test mice with +-I-q--I- lesions in different dilutions 
10-I 
9 
++ 
+ 
10-2 
8 
10 
10 
lOI 
10 
++++ 
++++ 
9 
++++ 
++++ 
5 
6 
10 
+++ 
++ 
+ 
1ol 
++ 
+ 
0 
+++ 
++ 
++ 
7 
10 
++++ 
+ 
+ 
o 
10~ 
8 
++++ 
++ 
+ 
+ 
0 
+1- 
I-- 
10-4 
++ 
++ 
+ 
++ 
0 
0 
+ 
0 
0 
+ 
0 
0 
0 
0 
0 
At 48 and 72 hours, however, as much as 100,000 M.L.D. of virus was 
detected  in  the  lungs.  Thereafter,  virus  was  found  in  the  lungs 
throughout  the  course  of  the  experiment  although  in  somewhat 
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Since in the preceding experiment no end point was reached as to 
the number of days virus persisted in the lungs, the procedure was 
repeated and extended to 11 days.  The results were quite parallel to 
those given above, especially in regard  to the low titer of virus in 
the lungs at the end of 24 hours and the rapid increase to a maximum 
in 48 to 72 hours.  In addition, sufficient virus was present in the lungs 
of mice 8, 9, and 10 days after intraperitoneal injection for a dilution 
of i: 1,000 to cause fatal infection in test mice, while on the llth day 
no  virus  was  demonstrable.  Obviously,  however,  the  duration  of 
virus in the lungs of mice in different experiments is variable. 
The presence of small amounts of virus in the lungs on the 1st day 
after  intraperitoneal  inoculation, the  rapid  increase  in  amount on 
the 2nd and 3rd days, and the persistence of virus over a prolonged 
period suggest that multiplication of the virus has taken place in the 
lungs.  Owing to the large amounts of virus injected, the possibility 
remains, however, that the virus has selectively localized in the lungs. 
This  hypothesis would demand acceptance of  the  idea that  either 
the virus is capable of surviving in the body in a relatively inert state 
for several days or that it is multiplying in other parts of the body 
and being transported to the lung.  In any case, it is apparent that 
following intraperitoneal inoculation of influenza virus the lung of a 
mouse may, without showing any evidence of pulmonary injury due to 
virus, contain virus in sufficient amount to kill 100,000 mice if inocu- 
lated  intranasally. 
Observations  upon  the  Distribution  of  Virus  after  Intraperitoneal 
Injection 
In order to evaluate the significance of the recovery of relatively 
large amounts of virus from the lungs of mice receiving influenza virus 
intraperitoneally, it was necessary to study further the distribution of 
virus in other organs and in the circulating blood.  If virus is con- 
sistently present in the blood, its presence in other organs and the 
mode of its transport to the lungs is readily explained. 
Presence of Virus in the Blood.- 
Three groups of 5 mice each were given approximately 100,000 ~.L.D. of virus 
intraperitoneally.  At 1, 3, and 4½ hour intervals, respectively, 10 drops of blood E.  R.  RICKARD AND  THOMAS FRANCIS, JR.  961 
were obtained from the tail vein of each mouse of one group.  Blood from each 
group was pooled, ground with alundum in 1.0 cc. of broth, and the supernatant 
fluid was inoculated into the nostrils of 3 normal mice.  When the mice which 
received the blood were killed 3 days later no lung lesions were seen, but a second 
serial passage made with lungs of these mice resulted in death of all second passage 
mice with influenza virus infection as confirmed  by neutralization tests. 
Thus the presence of virus in the blood was demonstrated from 1 to 
4½ hours after its introduction into the peritoneal cavity.  Using the 
same procedures, however,  repeated attempts  to demonstrate virus 
in  the  blood from  24  hours  to  6  days  after inoculation have  been 
uniformly unsuccessful. 
TABLE V 
Virus Demonstrated in Blood and Lungs of Individual  Mice after Intraperitoneal 
Inoculation 
l on  0  0  0 d 0  0J++:+ 
Virus in lungs  3 days  after inoculation.  0  0  -[-  0  -bN  0  +  0 
In Table V. 
-t-  ffi virus present. 
0 -- no virus present. 
N m positive neutralization test with influenza  immune serum. 
A further experiment was done in which 9 mice were injected intra- 
peritoneally with approximately 10,000 intranasal ~.LD. by the same 
technique as  above.  The blood of each mouse  was  tested  for the 
presence of virus 3 hours after inoculation and the lungs of each mouse 
were tested on the 3rd day after injection.  Virus was detected in the 
blood of 4  of the 9  mice and  the nature of  the  virus confirmed by 
neutralization tests in mice.  No virus was found in the lungs.  This 
dose of virus is, of course, below the threshold which ordinarily results 
in demonstrable virus in the lungs. 
The results of a similar experiment in which 100,000 ~.L.D.  of virus 
were  given  intraperitoneally to  10  mice  are  briefly summarized  in 
Table V.  Virus was demonstrated in the blood of 4 of the  10 mice 
3 hours after intraperitoneal injection, and in the lungs of 5 of the 10 
mice 3  days later.  In  2  of the mice virus was found in  the blood 
and again subsequently in the lungs.  In 2 of the mice virus was found 962  LESIONS  IN  INFLUENZA  VIRUS-INOCULATED  LUNGS 
in the blood but was not in the lungs 3 days later.  In 3 instances virus 
was present in the lungs although not demonstrable in the earlier tests 
of the  blood.  In  3  instances  virus was not  demonstrated  in  either 
the  blood  or  lungs.  These  experiments  demonstrate  that  shortly 
after  the  intraperitoneal  inoculation  of virus,  the  agent  can  be re- 
covered  from  the  circulating  blood.  Little  information  is  elicited, 
however, as to the relation between circulating virus and the presence 
of virus in the lungs.  That virus can be obtained from the lung follow- 
ing intravenous  injection  will be subsequently shown  (Table  VIII). 
The  significance  of the  results will be discussed more thoroughly in 
that  connection. 
Presence of Virus in Organs Other than the Lung.--In an experiment 
to determine the distribution of influenza virus in the body after the 
intraperitoneal  injection  of large doses of the agent,  mice so treated 
were killed after 3 hours, and others on the 3 following days.  In addi- 
tion to the blood and peritoneal washings, the lungs, nasal turbinates, 
liver,  spleen,  and  kidneys were examined  for the  presence  of virus, 
utilizing 2 serial passages in normal mice for this purpose. 
Blood  was  examined by  the  procedure  previously  described.  Peritoneal 
washings were obtained by flushing the abdominal contents with approximately 
1.0 cc. of broth which was then inoculated in 0.05 cc. amounts intranasally to test 
mice.  The abdominal organs were vigorously washed 5 times in 20 cc. amounts of 
Locke's solution, an amount thought to be sufficient to eliminate any virus that 
might be present on the surface of the organs.  A 10 per cent suspension of each 
organ in broth was then given intranasally to mice. 
Three hours after intraperitoneal  inoculation,  virus was present in 
small but demonstrable amounts in the blood; it was present iu larger 
amounts in the peritoneal washings and lungs, but not demonstrable 
in the nasal turbinates.  On all 3 days thereafter virus was recovered 
from the peritoneal washings and lungs but not from the turbinates. 
Although  positive  results  were  obtained  in  examination  of  liver, 
spleen, and kidneys the difficulty in eliminating direct contamination 
from the peritoneal cavity makes their evaluation uncertain.  This is 
emphasized by a  control experiment in which 2 mice were killed and 
immediately  given  1.0  cc.  of  1 per  cent  virus  suspension  intraperi- 
toneally.  After  abdominal  massage,  liver,  spleen,  and  kidney were 
removed, subjected to the same amount of washing, and then tested 
for the presence of virus.  Virus was recovered from all the organs. E.  R.  RICKARD  AND  THOMAS  FRANCIS,  JR.  963 
The tendency of the virus to remain in the peritoneal washings and 
in the abdominal viscera suggested that  the virus is taken  up by the 
serosal  cells  of  the  peritoneum  and  the  capsules  of  the  abdominal 
organs.  This suggestion was tested in the following experiment. 
Six  mice were injected  intraperitoneally  with  100,000  ~.L.D.  of virus.  The 
mice were bled and killed in groups of 2 on the 1st, 3rd, and 6th days following 
inoculation.  Peritoneal washings were obtained in the manner already described. 
The intestines were removed and abdominal cavities vigorously flushed  14  times 
TABLE  VI 
The Distribution of Virus after Intraperitoneal Injection in Mice 
Organs  examined 
Blood ............. 
Peritoneal  wash- 
ings ............ 
Mesentery and pa- 
rietal peritoneum. 
Lungs ............ 
Turbinates ....... 
Deaths and lesions in test mice 
A 
0 
6, 
+ 
5, 
0 
Ist day 
B  C 
0  O0  0  0 
6  8, 8  .... 
0  ++0  4,  6 
5  6, 7 
0  00  0  0 
3rd day 
A  B 
0  0  0  C 
+  +  10, l0 
4,  4  4,  4 
4,  4  4,  5 
0  0  0  0 
c 
0  0 
4,  4 
0  0 
00 
00 
++ 
00 
00 
6th day 
B 
00 
00 
7, 7 
00 
00 
C 
00 
00 
5, 5 
00 
00 
In Tables VI and VIII. 
A  -  day of death with  +  +  +-t- lesions or lesions seen when mice were killed 
on 4th day after inoculation; primary passage mice. 
B  -- day of death with % % +  % lesions or lesions seen when mice were killed 
on 10th day after inoculation; primary passage mice. 
C  -  day of death with W + +  +  lesions or lesions seen when mice were killed on 
10th day after inoculation; secondary passage mice. 
with  12 cc. of saline per flushing, after which pieces of mesentery and parietal 
peritoneum were made into 10 per cent suspension for inoculation into test mice. 
Peritoneal washings and suspensions of blood, lungs, and turbinates were likewise 
inoculated.  Except in cases where death had already occurred or the test mice 
were obviously ill, on the 4th day following inoculation 2 of the group were killed 
(A) and secondary passage made to 2 additional mice (C); the remaining 2 of the 4 
original test mice (B) were kept until the 10th day when survivors were killed and 
lesions observed. 
As observed in Table VI virus was found in the peritoneal washings 
as long as 3 days after its injection, while in the cells of the mesentery 
and parietal peritoneum virus was demonstrable as late as 6 days after 964  LESIONS  IIft  INFLUENZA  VIRUS-IN'OCULATED  LUNGS 
injection.  The latter observation shows clearly the  capacity of the 
virus to survive and perhaps  to multiply in the peritoneal cells.  In 
contrast  to these results is the absence of virus from the blood and 
nasal  turbinates.  Virus was not recovered from the lungs after the 
3rd day, a  result perhaps due to the factor of individual variation in 
the mice. 
The Development  of  Resistance  in Mice Receiving  Large Doses of 
Influenza Virus IntraperitoneaUy 
It  has  been  clearly  shown that  as  a  result  of the  intraperitoneal 
inoculation  of mice with  the  larger  doses of influenza  virus  a  high 
concentration of the virus and gross pathological changes are found in 
the lungs of the animals.  In view of these facts it is noteworthy that 
in a large series of observations upon mice so inoculated no deaths from 
influenza  virus  infection  have  occurred.  This  result  is  even  more 
striking when it is recalled that as much as 100,000 intranasal lethal 
doses of virus  may  be  recovered  from  the  lung  of  a  mouse  which 
appears perfectly healthy after the intraperitoneal  injection of virus. 
It must be assumed either that the virus reaches the lungs by a route 
which prevents its attacking the pulmonary tissues in the same man- 
ner as after intranasal  inoculation  (2),  or that  an  alteration  in  the 
reactivity of the animal host occurs as a result of the pararespiratory 
injection  so as to inhibit  the virus from exerting its full pathogenic 
influence upon the pulmonary tissues to which it has gained access. 
The  fact that  the  pulmonary  lesions observed after  intraperitoneal 
inoculation of virus are rarely of more than moderate extent seems to 
support  the  latter  point  of  view.  Moreover,  the  animals  become 
solidly immune to subsequent intranasal tests with as much as 100,000 
~x.L.D. of virus. 
The  following  experiment  was  undertaken  to  determine  whether 
after the intraperitoneal  inoculation  of virus any evidence could be 
obtained of a rapidly developing resistance which might serve to pro- 
tect mice against the characteristic virus effect. 
Suspensions of 2 per cent mouse lung virus were prepared and stored in a freez- 
ing mixture (S) at -79  ° C. until used.  Every day for 5 days a different group of 
10 mice each was given 0.5 cc. of the virus suspension intraperitone~lly.  On the 
3rd day all mice, reg&rdless of whether or not they had yet received the virus E. R. RICKARD  AND  THOMAS  FRANCIS, JR.  965 
intraperltoneally, were given 0.05  cc.  amounts  of a  1:100,000 dilution of virus 
intranasally.  In  addition one group of  10  mice  received  only the intranasal 
inoculation,  while another group received only the intraperitoneal injection  of 
virus.  The mice were observed  for 10 clays at which  time all survivors  were 
sacrificed and the lungs examined.  The results  are summarized  in Table VII. 
As evidenced by the fact that all survived and that only low grade 
pulmonary lesions were  found at  autopsy, the  mice which  received 
the  intraperitoneal  inoculation  of  virus  2  days  before  intranasal 
infection exhibited a  well marked resistance.  This is especially ira- 
TABLE  VII 
The Effect of Intraperltoneul Injection of a Large Dose of Virus before and after the 
Intranasal Inoculation of a Small Infective Dose of the Same Virus 
Time relation of intra-  Day of death with q--k++ lesions or lesions seen in mice surviving 10 days after 
peritoneal to intrannsal  intrauasal inoculation 
inoculation 
2  days before .......  q--t-  -}-+ 
1 day before ....... 
Same day .......... 
1  day after  ....... 
2  days after ....... 
+  +  +  +  +  -4-  0  0 
7,  7  ++  ++  +  +  +  +  +  + 
6,  6,  7  +++  +++  ++  ++  ++  ++  ++ 
7,  7,  7,  7,  7,  7,  7  + +  + +  0 
6,  7,  7,  7,  7,  7,  9,  9,  10  ++++ 
Intranasal only  .....  7,  7,  7,  8,  8,  8  +++  ++  ++  ++ 
Intraperitoneal  only.  "t-  q-  -t-  "b  0  0  0  0  0  0 
pressive when one considers that the intranasal infection was given at 
about the time when the amount of virus recoverable from the lung 
following intraperitoneal injection  reaches its maximum.  Although 
to a  lesser extent, a  similar effect was observed in the mice receiving 
virus intrapefitoneally 24 hours before intranasal infection.  There- 
after, the severity of the pulmonary lesions and the frequency of death 
increased  so  that  animals  receiving  intraperitoneal  virus  after  the 
intranasal infection showed no evidence of resistance.  Similar results 
were  obtained when these  observations were  repeated  using  10  per 
cent virus concentration for the intraperitoneal injection. 
Since the resistance  developed so rapidly it was of further interest 
to ascertain what correlation, if any, obtained between the active re- 
sistance of the  animals and the  development of circulating antiviral 
substances.  Accordingly, each of 45 mice was given the equivalent 966  LESIONS  IN  INFLUENZA  VIRUS-INOCULATED  LUNGS 
of 50,000 to 100,000 intranasal M.L.D. intraperitoneally.  At intervals 
of approximately every 3 days from 1 to 27 days thereafter, groups of 
5 mice were bled from the tail veins.  The serum of each group was 
pooled and tested for the presence of antibodies to influenza virus by 
means of the protection test in mice.  No antibodies were detected in 
the serum taken 1 or 3 days after intraperitoneal inoculation.  On the 
5th,  7th, and 10th days sufficient antibody was present in undiluted 
serum to protect test mice against fatal infection with  1,000  lethal 
doses of virus even though some pulmonary involvement was observed. 
On the 13th day the serum had a protective titer between 1 : 100 and 
1:200,  and  this  level was maintained until  the  termination of the 
experiment on the 27th day. 
It  appears,  therefore, that  the resistance exhibited to  intranasal 
virus infection by mice which receive large doses of influenza virus 
intraperitoneally is  effective at  the very time maximal amounts of 
virus tend to collect in the lungs and, on the basis of the preceding 
experiment, before neutralizing antibodies are detectable in the blood. 
This  apparently  non-specific  resistance  may possibly  represent  an 
example of the interference phenomenon similar to that described for 
yellow fever virus (6), when the neurotropic strain of virus given to 
monkeys intraperitoneally protects against an otherwise fatal infection 
with the viscerotropic strain of virus.  Further investigation of the 
nature of the resistance observed in the present experiments will be 
required. 
Distribution of Virus after Subcutaneous or Intravenous Administration 
The foregoing experiments have revealed that after the intraperi- 
toneal inoculation of mice with large amounts of influenza virus the 
virus can be recovered from the blood for a  short time and from the 
lungs in relatively high concentrations for a number of days.  When 
the same procedures were applied after the subcutaneous inoculation 
of similar amounts of virus, virus was not demonstrable in the blood 
or lungs of the mice.  Moreover, one large dose of virus  subcuta- 
neously results not only in a less effective active immunity among the 
treated mice but also in a lower titer of neutralizing antibodies in the 
blood than when the same amount of virus is given by the intraperi- 
toneal  route.  Virus  was  readily  recovered, however, from  the  re- E.  P..  RICKARD  AND  TEOMA.S FRANCIS,  JR.  967 
gional lymph nodes in large quantities after 4 hours, still demonstrable 
but considerably diminished after 24 hours, but no longer detectable 
after 48 hours.  The results suggest that in mice following subcuta- 
neous inoculation of influenza virus, the virus is absorbed in regional 
lymphatics and is there destroyed without invasion of the blood stream 
or of the lungs in contradistinction to the course of events after intra- 
peritoneal inoculation. 
Attempts to determine the effects produced by virus administered 
intravenously to mice were impeded at first by a toxic effect of suspen- 
sions of mouse lung tissue which resulted in the immediate death of 
most mice with symptoms of acute "pulmonary" shock.  It was sub- 
sequently found that prolonged centrifugation of the material reduced 
its toxicity sufficiently to permit the inoculation of larger groups of 
mice although toxic symptoms with occasional deaths still occurred. 
The following experiment illustrates the results obtained. 
Five mice anesthetized with ether were given into the tail veins 0.25 cc. of 5 
per cent suspension of mouse lung virus in 10 per cent normal mouse serum in 
Locke's solution.  The suspension had been previously centrifuged for 1 hour at 
2,500 R.P.~., and when titrated intranasally in mice a dilution of 1  : 100,000 caused 
death.  Therefore, approximately 25,000 intranasal  ~.L.D. were administered 
intravenously.  Individual  mice were exsanguinated from the  heart  after  30 
minutes, and 1, 2, 4, and 6 days following  inoculation.  The abdominal viscera 
were removed at the same time.  The blood was ground with 1.0 cc. of broth and 
10 per cent suspensions made of liver, spleen, kidney, and lung, care being taken to 
avoid cross contamination of organs.  Groups of 4  test  mice were inoculated 
intranasally with 0.05 cc. amounts of each blood and organ suspension. 
The results of the present experiment, summarized in Table VIII, 
show that following intravenous administration of large doses of virus, 
virus  may be  demonstrated consistently in  the  lungs,  and  typical 
influenzal  pulmonary  lesions  may  occur.  Results  obtained  from 
examination of the other organs and the blood must be considered as 
preliminary observations.  They are  included,  however,  because  of 
the interesting tendency of the virus to localize and persist in the liver. 
While no explanation can be offered at present in regard to this phe- 
nomenon, the similarity in embryological origin of the lung and liver 
as well as certain structural similarities might be borne in mind.  It is 
of further interest as well that virus administered intravenously is 968  LESIONS  IN  INFLUENZA  VIRUS-INOCULATED  LUNGS 
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rapidly removed from the blood but persists in relatively high concen- 
tration in the lungs.  The virus has undoubtedly been transported 
to the lung by way of the blood stream and concentrated there.  These 
observations may aid in understanding the route by which virus from 
the peritoneal cavity reaches the lung.  It is impossible at present, 
however, to decide whether the virus in the lung reaches its concen- 
tration merely by selective localization or to what extent it represents a 
result of virus multiplication. 
DISCUSSION 
It has been shown in the foregoing experiments that, following the 
intraperitoneal inoculation of mice with large doses of epidemic in- 
fluenza virus,  the virus reaches the  lungs  and  may  there  produce 
macroscopic lesions  of  epidemic influenza  virus  infection.  These 
results are obtained only when virus is administered intraperitoneally 
in amounts equivalent to more than  10,000  intranasal lethal doses. 
It is quite remarkable, however, that although as much as  100,000 
M.L.D. of virus may be recovered from the lungs of mice and the virus 
may persist in the lungs from 4 to 10 days, pulmonary lesions of more 
than moderate extent have not been observed, nor have any fatalities 
due to virus infection occurred among the many mice subjected to the 
procedure.  This is in striking contrast to the effects observed after 
intranasal inoculation of mice in which instance minute amounts of 
influenza virus cause a  fatal  disease with  complete pulmonary in- 
volvement.  The capacity of the virus to inflict pulmonary damage is 
obviously influenced by the route by which it reaches the lung, and 
the mechanism of its action must differ under the  two conditions. 
It is difficult to decide whether the virus reaches its relatively high 
concentration in the lung as a  result of multiplication in that organ 
or whether it is concentrated in the lung as a result of selective localiza- 
tion on transport from other parts of the body.  In favor of the latter 
hypothesis are the facts that the virus does not exert its complete, 
pathogenic action in the lung after intraperitoneal inoculation, and 
that an available source for feeding virus to the lung is in the perito- 
neal cells where virus has been shown to persist, if not multiply, for 
several days.  Furthermore, virus is recovered from the lungs only 
after maximal intraperitoneal doses, indicating that for it to reach the 970  LESIONS  IN  INFLUENZA  VIRUS-INOCULATED  LUNGS 
lung a flooding of the body must occur.  On the other hand, a mode of 
transport is not readily apparent, for virus has not been recovered 
from the blood later than 24 hours after its introduction into the peri- 
toneal cavity.  Moreover, since such large amounts of virus intra- 
peritoneaUy are required to permit the detection of virus in the lung, 
it may be that any virus which reaches the lung can subsequently 
multiply.  This is suggested by the fact that the highest concentra- 
tion of virus in the lung is usually encountered 24 to 48 hours after 
virus can be recovered from the blood.  At present, however, no final 
conclusion appears warranted. 
As previously stated, mice whose lungs contain relatively high con- 
tents of influenza virus and present macroscopic lesions subsequent 
to the intraperitoneal injection of virus show no external evidence of 
infection.  They do not die but become staunchly immune to infection 
by  the  intranasal  route.  The  failure  of  the  virus to  induce fatal 
infection in mice under these conditions immediately suggests that 
the animal develops an increased resistance capable of inhibiting the 
pathogenicity of the virus which is abundantly present in susceptible 
tissues.  It was shown, in fact, that mice which were given large doses 
of virus intraperitoneaUy 48 hours before the intranasal introduction 
of a fatal dose of virus resisted the fatal infection.  The lethal intra- 
nasal dose of virus was given at the time when the highest concen- 
tration of virus in the lung is reached as a result of the intraperitoneal 
inoculation.  It is extremely interesting that  instead of lending an 
added effect to the intranasal dose, an antagonistic effect was observed. 
On  the basis  of  the  experiments recorded above,  the  resistance  is 
active  before demonstrable antiviral  substances are  present in  the 
blood.  The  studies of Hoskins  (6)  with  yellow fever virus  are  of 
interest in suggesting an interpretation of the present results.  Hos- 
kins observed that when the neurotropic strain of yellow fever virus 
was given to monkeys by the intraperitoneal route, the animals were 
rendered resistant to fatal infection by the viscerotropic strain of virus 
given as much as  24 hours previously.  It may be  in  the present 
instance that the virus of influenza entering the pulmonary tissues v/a 
the peritoneal route renders the cells refractory to fatal infection with 
the same virus administered 48 hours later by the intranasal route. E.  R.  RICKARD AND  THOMAS ~RANCIS~ JR.  971 
Following the same reasoning it might be suggested that the solid 
immunity to intranasal infection which follows intraperitoneal vacci- 
nation with active influenza virus is entirely attributable to a localiza- 
tion of the immunizing  virus in the lungs, and that unless virus reaches 
and multiplies in the lungs no immunity is produced.  This concept 
is immediately eliminated by reference to the successful vaccination 
of mice with inactive formalized virus (7).  Furthermore, in the course 
of the present studies it has been possible to show that fully active 
immunity can be induced by the intraperitoneal injection of active 
virus cultivated in tissue culture medium (8, 9)  although it has not 
been possible to detect its presence in the lungs of vaccinated mice, 
even after repeated passages. 
SUMMARY 
Following the intraperltoneal inoculation of mice with large doses 
of epidemic influenza  virus  (50,000  to  1 million intranasal  ~.L.D.) 
it can be recovered from the lungs in high concentration, and pul- 
monary lesions  of  moderate  extent  may  he  observed.  The  virus 
reaches its highest titer in the lungs 48 to 72 hours after intraperitoneal 
injection and may persist for 10 days.  Virus may be recovered from 
the blood in the first 24 hours, but is readily detected in the omentum 
and peritoneum for 5 to 6 days.  Mice which as a result of the intra- 
peritoneal injection of virus show a high concentration of virus in the 
lungs do not die but become solidly immune to intranasal infection. 
Moreover, as early as 24 to 48 hours after intraperitoneal inoculation 
of large amounts of virus the animals may exhibit resistance to infec- 
tion with fatal doses of virus given intranasally. 
Influenza virus given intravenously to mice is rapidly removed from 
the blood but persists in the lungs and induces pulmonary lesions. 
Virus can also be recovered from the liver for several days.  With 
subcutaneous inoculation of influenza virus, however, the virus does 
not  reach  the  blood  or lungs in  detectable  amounts although the 
regional  lymph  nodes  may  yield  considerable  quantities  of  the 
agent. 
A  brief consideration is presented of the mechanisms of infection 
and resistance which may be involved. 9?2  LESIONS  IN INFLUENZA  VIRUS-INOCULATED  LUNGS 
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